← All trials

NCT04641962

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Feb 28, 2021
Primary completion
Oct 31, 2023
Completion date
May 31, 2024
First posted
Nov 24, 2020
Last posted
Dec 24, 2020
Enrollment
149
Arms / groups
6 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.